• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Ei­sai chief Ivan Che­ung 'not wor­ried at al­l' about Leqem­bi's full ap­proval

3 years ago
Pharma

Sanofi ex­tends com­mit­ment to $750M biotech start­up fund

3 years ago
Financing
Startups

As Il­lu­mi­na dis­ap­points Wall Street, com­peti­tors make their case at JPM

3 years ago
R&D

Flame Bio­sciences search­es for fu­ture af­ter No­var­tis flunks on canakinum­ab

3 years ago
Startups
R&D

Ver­tex gets more pre­cise with Ar­bor in ex­pand­ed gene edit­ing pact

3 years ago
Startups
Deals

As­traZeneca and Avil­lion win ap­proval for new asth­ma res­cue treat­ment in adults

3 years ago
Pharma
FDA+

Da­ta to dol­lars: Geron sells stock to raise over $200M af­ter PhI­II read­out on MDS drug

3 years ago
Financing

Up­dat­ed: Roche, Io­n­is launch new Hunt­ing­ton’s dis­ease study

3 years ago
R&D

Spec­trum Labs is­sues world­wide re­call of ep­i­neph­rine in­gre­di­ent

3 years ago
Pharma
Manufacturing

Supreme Court re­jects Pfiz­er's bid to re­view an­ti-kick­back case

3 years ago
Pharma
Law

Co­herus pays out $32M for ex­clu­sive US com­mer­cial­iza­tion rights to Eylea biosim­i­lar

3 years ago
Deals

Next-gen Covid vac­cines: No more quick vari­ant up­dates and RCTs may be re­quired, CBER leader writes

3 years ago
FDA+
Coronavirus

Re­silience starts the year with its first deal out­side of North Amer­i­ca

3 years ago
Deals
Manufacturing

Ar­row­head, Take­da liv­er drug head­ed to PhI­II de­spite place­bo re­spon­se's dent on stock

3 years ago
R&D

Ster­ling Phar­ma com­pletes ac­qui­si­tion of No­var­tis man­u­fac­tur­ing plant in Ire­land

3 years ago
Pharma
Manufacturing

Arv­inas re­ports de­lay for Pfiz­er-part­nered pro­tein degra­da­tion pro­gram

3 years ago
R&D

FDA puts Ver­tex’s new Type 1 di­a­betes cell ther­a­py IND on hold; In­sil­i­co sets up for PhII of AI drug

3 years ago
R&D
News Briefing

Ab­b­Vie signs mR­NA pact with An­i­ma Biotech for $42M up­front

3 years ago
Deals
AI

Ei­sai fol­lows fam­i­ly ties with name for new­ly ap­proved Alzheimer's drug Leqem­bi

3 years ago
Pharma
Marketing

4D Mol­e­c­u­lar paus­es en­roll­ment in Fab­ry tri­als af­ter kid­ney prob­lems in three pa­tients

3 years ago
R&D
Cell/Gene Tx

ICY­MI: FDA com­mis­sion­er calls for more on­shoring of clin­i­cal tri­als

3 years ago
FDA+

Mar­ket­ingRx roundup: Blue­bird bio pro­motes sick­le cell aware­ness; Pfiz­er, BioN­Tech en­cour­age boost­ers in South

3 years ago
R&D

Q&A: Genen­tech's first mar­ket­ing chief Er­i­ca Tay­lor on lessons from the pan­dem­ic, and what's next for the Roche group

3 years ago
Pharma
Marketing

Jasper scraps piv­otal plans but adds a new in­di­ca­tion as more biotechs re­vise pipelines

3 years ago
Startups
R&D
First page Previous page 392393394395396397398 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.